Skip Navigation LinksHome > April 2014 - Volume 76 - Issue 4 > Predictive factors for failure of nonoperative management in...
Journal of Trauma and Acute Care Surgery:
doi: 10.1097/TA.0000000000000187
Original Articles

Predictive factors for failure of nonoperative management in perforated appendicitis

Maxfield, Mark W. MD; Schuster, Kevin M. MD; Bokhari, Jamal MD; McGillicuddy, Edward A. MD; Davis, Kimberly A. MD, MBA

Collapse Box

Abstract

BACKGROUND

Identifying patients on admission with perforated appendicitis who have phlegmon or abscess initially selected for but likely to fail nonoperative management may avoid delays in definitive treatment.

METHODS

Patients older than 15 years presenting to a university tertiary care hospital with perforated appendicitis and abscess or phlegmon and planned nonoperative management were reviewed. Comorbidities, clinical findings, laboratory markers, radiographic findings, and nonsurgical treatments associated with failure of nonoperative management were recorded.

RESULTS

Eighty-nine patients were identified, and 69 were managed successfully to discharge without operation. Length of stay was greater in the failure group (11 days vs. 5 days, p = 0.001), and intensive care unit care was more common (10% vs. 0%, p = 0.049). On univariate and multivariate analyses, smoking (odds ratio [OR], 13.20; 95% confidence interval [CI], 1.13–142; p = 0.039), tachycardia (OR, 4.93; 95% CI, 1.21–20.06; p = 0.026), and generalized abdominal tenderness (OR, 5.52; 95% CI, 1.40–21.73; p = 0.015) were associated with failure of nonoperative management. On computed tomographic scan, the failure group had higher rates of abscess (75% vs. 55%, p = 0.110), and their abscesses were more likely smaller than 50 mm (OR, 2.83; 95% CI, 1.01–7.92; p = 0.043).

CONCLUSION

Patients with perforated appendicitis and phlegmon or abscess who smoke or present with tachycardia, generalized abdominal tenderness, and abscesses smaller than 50 mm are more likely to fail nonoperative management and should be considered for early operation. These findings should be validated prospectively.

LEVEL OF EVIDENCE

Therapeutic study, level III.

Copyright © 2014 by Lippincott Williams & Wilkins

Follow Us


Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.